financetom
PHR
financetom
/
Healthcare
/
PHR
All stocks News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Commodities
Phreesia, Inc.PHR
USD
- At close
USD
- Until the end
The complete list of US stocks
1D
5D
1M
1Y
5Y
MAX
Overview >
% Change
Description >

Phreesia, Inc. provides an integrated SaaS-based software and payment platform for the healthcare industry in the United States and Canada.

Its Phreesia Platform offers access solutions that offers appointment scheduling system for online appointments, reminders, and referral tracking; registration solution to automate patient self-registration; revenue cycle solution, which offer insurance-verification processes, point-of-sale payments applications, post-visit payment collection, and flexible payment options; and network connect solution to deliver clinically relevant content to patients.

The company deploys its platform in a range of modalities, such as Phreesia Mobile, a patients' mobile device; Phreesia Dashboard, a web-based dashboard for healthcare services clients; PhreesiaPads, a self-service intake tablets; and Arrivals Kiosks, an on-site kiosks.

It serves patients; single-specialty practices, multi-specialty groups, and health systems; and pharmaceutical, medical device, and biotechnology companies.

The company was incorporated in 2005 and is headquartered in Wilmington, Delaware.

Latest News >
--PayPal Planning to Build Ad Business, The Wall Street Journal Reports
--PayPal Planning to Build Ad Business, The Wall Street Journal Reports
May 28, 2024
07:34 AM EDT, 05/28/2024 (MT Newswires) -- Price: 62.42, Change: +0.78, Percent Change: +1.27 ...
Baozun Beats Revenue Estimates with Strong Q1 Growth, Shares Surge
Baozun Beats Revenue Estimates with Strong Q1 Growth, Shares Surge
May 28, 2024
Baozun Inc ( BZUN ) reported a fiscal first-quarter 2024 revenue growth of 4.9% year-on-year to 1.98 billion Chinese yuan ($274.2 million), beating the analyst consensus estimate of $269.6 million. Adjusted loss per ADS was $0.03, compared to the analyst consensus estimate of $0.00. The stock price gained after the results. The increase in total net revenues was mainly due to higher product sales...
Merck Says Phase 3 Trial of Keytruda in Triple Negative Breast Cancer Met Overall Survival Endpoint
Merck Says Phase 3 Trial of Keytruda in Triple Negative Breast Cancer Met Overall Survival Endpoint
May 28, 2024
07:34 AM EDT, 05/28/2024 (MT Newswires) -- Merck ( MRK ) said Tuesday that a phase 3 trial evaluating Keytruda in combination with chemotherapy as a treatment for patients with high-risk early-stage triple-negative breast cancer met its overall survival endpoint. The trial evaluated the combination therapy as a pre-operative treatment and as a single agent after surgery, Merck ( MRK...
Energy Capital Partners to acquire Atlantica for $2.56 bln
Energy Capital Partners to acquire Atlantica for $2.56 bln
May 28, 2024
May 28 (Reuters) - Private equity firm Energy Capital Partners will buy Atlantica Sustainable Infrastructure ( AY ) for $2.56 billion in cash, the utility said on Tuesday, in a deal that will give its biggest shareholder funds to lower its debt. Atlantica, which started a strategic review in February last year, will get $22 per share, a near 19%...
Copyright 2023-2025 - www.financetom.com All Rights Reserved